Both in Pharmaceuticals
Innovator U.S. Equity Ultra Buffer ETF - November vs AB Corporate Bond ETF
Over the past year UNOV returned +10.4% and EYEG returned −7.6%; their daily moves had a correlation of 0.41.
UNOV +10.4% EYEG −7.6%Growth of $1, one year, split-adjusted
| Metric | UNOV | EYEG |
|---|---|---|
| Price | $41.36 | $33.45 |
| Market cap | $106.5M | $26.8M |
| Today | −0.24% | −0.61% |
| 1 month | +0.6% | −3.6% |
| 6 months | +12.4% | −4.2% |
| Year to date | +8.7% | −6.5% |
| 1 year | +10.7% | −7.3% |
| Revenue growth (YoY) | +3.0% | — |
| Gross margin | 69.0% | — |
| Net margin | 8.0% | — |
| P/E (TTM) | 27.4× | — |
| Price / sales | 3.0× | — |
| Net cash | $2.8M | $16.8M |
| Dividend yield | — | 4.61% |
| Volatility (60d) | 5.1% | 5.0% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).